This is truly exciting!
increase in awareness and media coverage
credibility bump due to being selected in this this trial by the prestigious CSIRO
(if successful) possible new huge revenue stream
However for me the most exciting part is
4. the chance of rapidly accelerated clinical trials.
If this does show effectiveness through this initial trial, surely it will open the door for an accelerated human trial like the ones being done all over the globe? This data could be used to complement FDA submissions for the superbug applications as well??
Again, they need to get through the trial first but a great result. Great work RCE team!
- Forums
- ASX - By Stock
- RCE
- Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online